RECESSIVE X-LINKED ICHTHYOSIS

Clinical trials for RECESSIVE X-LINKED ICHTHYOSIS explained in plain language.

Never miss a new study

Get alerted when new RECESSIVE X-LINKED ICHTHYOSIS trials appear

Sign up with your email to follow new studies for RECESSIVE X-LINKED ICHTHYOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New ointment shows promise for rare, severe dry skin disease

Disease control Completed

This study tested two strengths of an ointment (TMB-001) in 34 people aged 9 and older with congenital ichthyosis, a rare genetic condition causing thick, scaly skin. The goal was to see if the ointment could safely reduce scaling and improve skin appearance. Participants applied…

Matched conditions: RECESSIVE X-LINKED ICHTHYOSIS

Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control

Last updated Jun 12, 2026 12:08 UTC

RECESSIVE X-LINKED ICHTHYOSIS

Get alerted when new RECESSIVE X-LINKED ICHTHYOSIS trials appear

New ointment shows promise for rare, severe dry skin disease